{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:38:03Z","timestamp":1769841483373,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001127","name":"Genentech Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12325-025-03171-1","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:03:06Z","timestamp":1743073386000},"page":"2526-2536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fertility Outcomes in Risdiplam-Treated Male Patients with Spinal Muscular Atrophy: A Multicenter Case Series"],"prefix":"10.1007","volume":"42","author":[{"given":"Shelley","family":"Coskery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Erdler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret R.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/B978-0-323-37101-8.00139-9","volume-title":"Swaiman's pediatric neurology: principles and practice","author":"B Darras","year":"2017","unstructured":"Darras B, Monani U, De Vivo D. Genetic disorders affecting the motor neuron: spinal muscular atrophy. In: Swaiman K, Ashwal S, Ferriero D, et al. editors. Swaiman\u2019s pediatric neurology: principles and practice. 6th ed. Amsterdam: Elsevier; 2017. p. 1057\u201364.","edition":"6"},{"issue":"7","key":"3171_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/archdischild-2021-323605","volume":"108","author":"VL Gowda","year":"2023","unstructured":"Gowda VL, Fernandez-Garcia MA, Jungbluth H, Wraige E. New treatments in spinal muscular atrophy. Arch Dis Child. 2023;108(7):511\u20137.","journal-title":"Arch Dis Child"},{"key":"3171_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jns.2018.03.001","volume":"388","author":"E Abati","year":"2018","unstructured":"Abati E, Corti S. Pregnancy outcomes in women with spinal muscular atrophy: a review. J Neurol Sci. 2018;388:50\u201360.","journal-title":"J Neurol Sci"},{"key":"3171_CR4","unstructured":"Evrysdi (risdiplam). US prescribing information. https:\/\/www.gene.com\/download\/pdf\/evrysdi_prescribing.pdf. Accessed 18 Mar 2025."},{"issue":"15","key":"3171_CR5","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","volume":"61","author":"H Ratni","year":"2018","unstructured":"Ratni H, Ebeling M, Baird J, et al. Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA). J Med Chem. 2018;61(15):6501\u201317.","journal-title":"J Med Chem"},{"key":"3171_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2023.108360","volume":"118","author":"L Mueller","year":"2023","unstructured":"Mueller L, Barrow P, Jacobsen B, Ebeling M, Weinbauer G. Reproductive findings in male animals exposed to selective survival of motor neuron-2 (SMN2) gene splicing modifying agents. Reprod Toxicol. 2023;118:108360.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"3171_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40120-024-00626-5","volume":"13","author":"N Bar-Chama","year":"2024","unstructured":"Bar-Chama N, Elsheikh B, Hewamadduma C, Guittari CJ, Gorni K, Mueller L. Male reproduction in spinal muscular atrophy (SMA) and the potential impact of oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifiers. Neurol Ther. 2024;13(4):933\u201347.","journal-title":"Neurol Ther"},{"issue":"1","key":"3171_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s13023-024-03494-2","volume":"19","author":"A Magot","year":"2024","unstructured":"Magot A, Reignier A, Binois O, et al. Spinal muscular atrophy is also a disorder of spermatogenesis. Orphanet J Rare Dis. 2024;19(1):476.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03171-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:51:02Z","timestamp":1744872662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03171-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03171-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michael A. Lopez reports involvement in consulting and\/or clinical trials for Sarepta, Octapharma, and Pfizer. Shelley Coskery, Marcus Erdler, and Margaret R. Frey have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval for the cases from the Memorial Healthcare and University of Alabama were granted by the Western-Copernicus Group Institutional Review Board (2024-0786), an organization that is responsible for protecting the rights and well-being of patients who take part in research studies. The requirement for ethical approval was waived from the Clinic Donaustadt in Vienna, Austria. Patients signed informed consent regarding publishing their data. Data were collected only after the appropriate approvals and waivers had been received.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}